Evidence map›Paper›PMID 27241849›Full record

ArticleBiochimica et biophysica acta2016

A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection.

Andrea Troupin, Berlin Londono-Renteria, Michael J Conway, Erin Cloherty, Samuel Jameson, Stephen Higgs, Dana L Vanlandingham, Erol Fikrig, Tonya M Colpitts

Open access · hybridAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. TRIM Proteins in Host Defense and Viral Pathogenesis.Current clinical microbiology reports · 2020
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Andrea TroupinDepartment of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, United States.
Berlin Londono-RenteriaDepartment of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, United States.
Michael J ConwayFoundational Sciences, Central Michigan University College of Medicine, Mount Pleasant, MI 48859, United States.
Erin ClohertyDepartment of Tropical Medicine, Tulane University School of Public Health, New Orleans, LA 70112, United States.
Samuel JamesonDepartment of Tropical Medicine, Tulane University School of Public Health, New Orleans, LA 70112, United States.
Stephen HiggsBiosecurity Research Institute, Kansas State University, Manhattan, KS 66506, United States; Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506, United States.
Dana L VanlandinghamBiosecurity Research Institute, Kansas State University, Manhattan, KS 66506, United States; Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506, United States.
Erol FikrigSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, United States; Howard Hughes Medical Institute, Chevy Chase, MD 20815, United States.
Tonya M ColpittsDepartment of Pathology, Microbiology & Immunology, University of South Carolina School of Medicine, Columbia, SC 29209, United States. Electronic address: tonya.colpitts@uscmed.sc.edu.
University of South Carolina · USKansas State University · USTulane University · USCentral Michigan University · USYale University · US

Funding

Immunotherapeutics for Treatment of Flavivirus InfectionU01AI070343 · NIAID · YALE UNIVERSITY · PI FIKRIG, EROL · 2006 to 2010
$6.6M
The antiviral role of mosquito ubiquitin Ub3881 during dengue infectionK22AI103067 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI COLPITTS, TONYA MICHELLE · 2013 to 2014
$270k
Howard Hughes Medical InstituteNIAID NIH HHS K22 AI103067NIAID NIH HHS U01 AI070343
6 · The paper itself

Abstract

backgroundDengue virus (DENV) is a mosquito-borne flavivirus that causes significant human disease and mortality in the tropics and subtropics. By examining the effects of virus infection on gene expression, and interactions between virus and vector, new targets for prevention of infection and novel treatments may be identified in mosquitoes. We previously performed a microarray analysis of the Aedes aegypti transcriptome during infection with DENV and found that mosquito ubiquitin protein Ub3881 (AAEL003881) was specifically and highly down-regulated. Ubiquitin proteins have multiple functions in insects, including marking proteins for proteasomal degradation, regulating apoptosis and mediating innate immune signaling.

methodsWe used qRT-PCR to quantify gene expression and infection, and RNAi to reduce Ub3881 expression. Mosquitoes were infected with DENV through blood feeding. We transfected DENV protein expression constructs to examine the effect of Ub3881 on protein degradation. We used site-directed mutagenesis and transfection to determine what amino acids are involved in Ub3881-mediated protein degradation. Immunofluorescence, Co-immunoprecipitation and Western blotting were used to examine protein interactions and co-localization.

resultsThe overexpression of Ub3881, but not related ubiquitin proteins, decreased DENV infection in mosquito cells and live Ae. aegypti. The Ub3881 protein was demonstrated to be involved in DENV envelope protein degradation and reduce the number of infectious virions released.

conclusionsWe conclude that Ub3881 has several antiviral functions in the mosquito, including specific viral protein degradation. GENERAL SIGNIFICANCE: Our data highlights Ub3881 as a target for future DENV prevention strategies in the mosquito transmission vector.

Indexed as

AedesAnimalsApoptosisCell LineDengueDengue VirusDown-RegulationGene ExpressionImmunity, InnateImmunoprecipitationInsect VectorsProteasome Endopeptidase ComplexTranscriptomeUbiquitinViral Envelope ProteinsVirionProteasome Endopeptidase ComplexUbiquitinViral Envelope ProteinsArbovirusDengue virusMosquito transmissionProtein degradationUbiquitin

Identifiers

PMID27241849
PMCPMC4949077
OpenAlexW2406133044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.